Engagements

ICC dispute over breach of supply

CRA was retained by claimant to provide expert reports and testimony in an ICC arbitration regarding damages pursuant to the failure of a supply agreement pertaining to a pharmaceutical product. CRA evaluated pricing, market trends, and profitability related to its damages opinion.

Related capabilities

Damages & Quantum
International Arbitration
Life Sciences Arbitration
Life Sciences Commercial Disputes
Life Sciences Litigation

Gregory K. Bell
Group Vice President and Life Sciences Practice Leader

Boston
+1-617-425-3357 gbell@crai.com
Archan Ruparel
he/him/his

Principal

Washington, DC
+1-202-662-3861 aruparel@crai.com

Financial Litigation & Regulation
CRA Insights

Were shareholders harmed by Senate Bill 21’s amendments to the Delaware General Corporation Law?

Delaware Governor Meyer signed into law Senate Bill 21 (SB21) in March 2025, updating Delaware’s corporate law, with some of the key provisions including safe...
Intellectual Property
Articles

Smallest saleable patent-practicing unit in life sciences disputes

In this article titled “Smallest saleable patent-practicing unit in life sciences disputes,” author Erin McDermott examines methods for calculating damages in...

Explore our thinking

Intellectual Property
Sponsorship & Speaking Engagement

October 22-24, 2025

Fort Worth, TX

EDTX Bench Bar Conference 2025

CRA is a proud sponsor of one of the nation’s top annual bench bar conferences, drawing judges, lawyers, topic speakers, guests and other participants from...

See all events

ICC dispute over breach of supply

Meet our team

Related insights

Were shareholders harmed by Senate Bill 21’s amendments to the Delaware General Corporation Law?

Smallest saleable patent-practicing unit in life sciences disputes

Upcoming events

EDTX Bench Bar Conference 2025